Keyphrases
Type 1 Diabetes Mellitus (T1DM)
100%
Type I Diabetes
74%
Cell Death Genes
52%
Transplantation Therapy
47%
Programmed Cell Death
47%
β-cell Dysfunction
44%
Islet Cells
42%
Hypoxia
42%
Islet Transplantation
37%
Pseudoislets
33%
Cellular Model System
33%
Islet Inflammation
33%
Insulitis
33%
Clinical Protocols
33%
Tumor Suppressor
33%
Cell Replacement Therapy
33%
Diabetic
28%
Islet
26%
Bioreactor
25%
Insulin-producing Cells
23%
B Cells
20%
Microgravity
17%
Extracellular Matrix
16%
Diabetes
14%
Studentship
14%
Cell Clusters
14%
Cell Culture
13%
Static Culture
12%
Cell Viability
11%
Islet Graft Function
9%
Graft Function
9%
Islet Graft
9%
Meeting Abstracts
9%
Pancreatic Cells
9%
Hypoglycemia
9%
Stem Cells
9%
Hypoxia-inducible factor-1α (HIF-1α)
9%
Newcastle
9%
Donor Tissue
9%
Damaging Effects
9%
Graft Survival
9%
Life-threatening
9%
Novel Treatments
9%
Three-dimensional (3D)
8%
β-Cell Survival
8%
Subcellular Localization
8%
Matrix Gene Expression
8%
Extracellular Matrix Genes
8%
Pdx1
8%
Extracellular Matrix Protein 1 (ECM1)
8%
Insulin Gene Expression
8%
Immunocytochemistry
7%
CD68
7%
CD-8
7%
Natural Killer Cells
7%
Forkhead Box P3 (FOXP3)
7%
CD20
7%
Ductal Cells
7%
Hypoxic Condition
7%
Normoxia
7%
Macrophages
7%
Medicine and Dentistry
Insulin Dependent Diabetes Mellitus
100%
Beta Cell
61%
Hypoxia
55%
Cell Death
55%
Programmed Cell Death
44%
Extracellular Matrix
38%
Cellular Model
33%
Cell Replacement Therapy
33%
Tumor Suppressor Protein
33%
Medicine
33%
Insulitis
33%
Cell Culture
27%
Gene Expression
22%
Islet Transplantation
22%
Diabetes
22%
Cell Viability
16%
Cell Survival
14%
Collagenase
11%
Hypoxia Inducible Factor 1
11%
Hypoglycemia
11%
Graft Survival
11%
Stem Cell
11%
CD8 Antigen
11%
Immunocytochemistry
9%
Macrophage
7%
Chlordane
7%
Transcription Factor FOXP3
7%
CD20
7%
Cytotoxic T-Cell
7%
Natural Killer Cell
7%
Scleroprotein
5%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Fibronectin
5%
Protein Expression
5%
Blood Glucose Monitoring
5%
Hypoxemia
5%
In Vitro
5%
Biomimetics
5%
Transcatheter Arterial Chemoembolization
5%
Patient with Type 1 Diabetes
5%
Hypoxic Cell
5%
Immunoglobulin Enhancer Binding Protein
5%
Blood Glucose
5%
Health Care Cost
5%
Necrosis
5%
Pancreas Cancer
5%
Cell Growth
5%
Glucose Metabolism
5%